Not actual patient.
management
Despite widely accepted testing protocols, challenges still exist in
the
management of hepatitis D
- If hep D antibodies are detected, hepatitis D virus (HDV) RNA tests should be conducted to diagnose active HDV infection1
- It is important to monitor ALT and inflammatory markers for those testing positive1
- For HDV-positive patients with elevated ALT, assess fibrosis and monitor HDV RNA and ALT every 3 months2
There are currently no FDA-approved therapies for hepatitis delta2
Treatment with hepatitis B nucleo(s)tide analogs is ineffective in HDV1
Keep up to date on news and info about hepatitis D and its management
STAY IN THE KNOWQuestions about hep B?
Visit hepBMD.comALT=alanine aminotransferase.
References: 1. Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67:1560-1599. doi:10.1002/hep.29800 2. Centers for Disease Control and Prevention. Hepatitis D questions and answers for health professionals. Updated March 9, 2020. Accessed August 9, 2021. https://www.cdc.gov/hepatitis/hdv/hdvfaq.htm